Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction

References

• Akashi, Y.J., Nef, H.M., and Lyon, A.R., 2015. Epidemiology and pathophysiology of Takotsubo syndrome. Nature reviews. Cardiology, 12 (7), 387–397.
   PubMed Web of Science ®Google Scholar
• Alehagen, U., et al., 2011. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA, 305 (20), 2088–2095.
   PubMed Web of Science ®Google Scholar
• Balling, L. and Gustafsson, F., 2014. Copeptin as a biomarker in heart failure. Biomarkers in medicine, 8 (6), 841–854.
   PubMed Web of Science ®Google Scholar
• Day, R.M., et al., 2003. Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine, 21 (5), 224–233.
   PubMed Web of Science ®Google Scholar
• EL Mahmoud, R., et al., 2008. Prevalence and characteristics of left ventricular outflow tract obstruction in Tako-Tsubo syndrome. American heart journal, 156 (3), 543–548.
   PubMed Web of Science ®Google Scholar
• Falkentoft, A.C., et al., 2018. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy. Journal of the American Heart Association, 7, e008123.
   PubMed Web of Science ®Google Scholar
• Frohlich, G.M., et al., 2012. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Int J cardiol, 154, 328–332.
   PubMed Web of Science ®Google Scholar
• Gandley, R.E., et al., 2016. Low soluble syndecan-1 precedes preeclampsia. PLoS one, 11 (6), e0157608.
   PubMed Web of Science ®Google Scholar
• Gu, Y.L., et al., 2011. Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clinical research in cardiology, 100 (12), 1069–1076.
   PubMed Web of Science ®Google Scholar
• Guillen, I., et al., 1995. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J physiol, 269, R229–35.
   PubMed Web of Science ®Google Scholar
• Heubach, J.F., Ravens, U., and Kaumann, A.J., 2004. Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Molecular pharmacology, 65 (5), 1313–1322.
   PubMed Web of Science ®Google Scholar
• Hunter, I., Rehfeld, J.F., and Goetze, J.P., 2011. Measurement of the total proANP product in mammals by processing independent analysis. Journal of immunological methods, 370 (1–2), 104–110.
   PubMed Web of Science ®Google Scholar
• Kurowski, V., et al., 2007. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest, 132 (3), 809–816.
   PubMed Web of Science ®Google Scholar
• Ky, B., et al., 2011. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circulation: heart failure, 4 (2), 180–187.
   PubMed Web of Science ®Google Scholar
• Lindberg, S., et al., 2015. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI. European journal of preventive cardiology, 22 (6), 693–700.
   PubMed Web of Science ®Google Scholar
• Li-Saw-Hee, F.L., Blann, A.D., and Lip, G.Y., 2000. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. Journal of the American College of Cardiology, 35 (7), 1926–1931.
   PubMed Web of Science ®Google Scholar
• Madhavan, M., et al., 2009. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart, 95 (17), 1436–1441.
   PubMed Web of Science ®Google Scholar
• Madhavan, M. and Prasad, A., 2010. Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis. Herz, 35 (4), 240–243.
   PubMed Web of Science ®Google Scholar
• Madias, J.E., 2015. Could myocardial inflammation in Takotsubo syndrome be secondary to the mechanical disruption, rather than a primary feature, of the illness? International journal of cardiology, 189, 196.
   PubMed Web of Science ®Google Scholar
• Maisel, A., et al., 2010. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Journal of the American College of Cardiology, 55 (19), 2062–2076.
   PubMed Web of Science ®Google Scholar
• Maisel, A., et al., 2013. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). Journal of the American College of Cardiology, 62 (2), 150–160.
   PubMed Web of Science ®Google Scholar
• Maisel, A.S., et al., 2002. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England journal of medicine, 347 (3), 161–167.
   PubMed Web of Science ®Google Scholar
• Meissner, J., et al., 2011. Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction. European journal of clinical investigation, 41 (9), 964–970.
   PubMed Web of Science ®Google Scholar
• Morel, O., et al., 2009. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. Journal of cardiac failure, 15 (3), 206–213.
   PubMed Web of Science ®Google Scholar
• Mueller, C., 2014. Biomarkers and acute coronary syndromes: an update. European heart journal, 35 (9), 552–556.
   PubMed Web of Science ®Google Scholar
• Mulivor, A.W. and Lipowsky, H.H., 2004. Inflammation- and ischemia-induced shedding of venular glycocalyx. American journal of physiology-heart and circulatory physiology, 286 (5), H1672–80.
   PubMed Web of Science ®Google Scholar
• Nef, H.M., et al., 2007. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. European heart journal, 28 (20), 2456–2464.
   PubMed Web of Science ®Google Scholar
• Nguyen, T.H., et al., 2017. Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathy. International journal of cardiology, 243, 296–299.
   PubMed Web of Science ®Google Scholar
• Ostrowski, S.R., et al., 2013. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Critical care, 17 (1), R32.
   PubMed Web of Science ®Google Scholar
• Paur, H., et al., 2012. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation, 126 (6), 697–706.
   PubMed Web of Science ®Google Scholar
• Pirzer, R., et al., 2012. Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy. Heart and vessels, 27 (2), 186–192.
   PubMed Web of Science ®Google Scholar
• Potocki, M., et al., 2012a. Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart, 98 (7), 558–565.
   PubMed Web of Science ®Google Scholar
• Potocki, M., Ziller, R., and Mueller, C., 2012b. Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?. Current heart failure reports, 9 (3), 244–251.
   PubMedGoogle Scholar
• Reichlin, T., et al., 2009. Incremental value of copeptin for rapid rule out of acute myocardial infarction. Journal of the American College of Cardiology, 54 (1), 60–68.
   PubMed Web of Science ®Google Scholar
• Santoro, F., et al., 2016. Serum interleukin 6 and 10 levels in Takotsubo cardiomyopathy: increased admission levels may predict adverse events at follow-up. Atherosclerosis, 254, 28–34.
   PubMed Web of Science ®Google Scholar
• Santoro, F., et al., 2018. Inflammatory patterns in Takotsubo cardiomyopathy and acute coronary syndrome: a propensity score matched analysis. Atherosclerosis, 274, 157–161.
   PubMed Web of Science ®Google Scholar
• Shan, J., et al., 2003. Autonomic and neuroendocrine actions of adrenomedullin in the brain: mechanisms for homeostasis. Regulatory peptides, 112 (1–3), 33–40.
   PubMedGoogle Scholar
• Slagman, A., et al., 2015. Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction. Clinical chemistry, 61 (10), 1273–1282.
   PubMed Web of Science ®Google Scholar
• Templin, C., et al., 2015. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. New England journal of medicine, 373 (10), 929–938.
   PubMed Web of Science ®Google Scholar
• Templin, C., et al., 2019. Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. European heart journal, 40 (15), 1183–1187.
   PubMed Web of Science ®Google Scholar
• Tseng, C.C.S., et al., 2018. Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device. European journal of clinical investigation, 48, e12886.
   Web of Science ®Google Scholar
• VON Kanel, R. and Dimsdale, J.E., 2000. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. European journal of haematology, 65 (6), 357–369.
   PubMed Web of Science ®Google Scholar
• Vriz, O., et al., 2015. ST2 marker might help to stratify in-hospital high risk patients with Tako-tsubo cardiomyopathy. European journal of internal medicine, 26 (2), 144–145.
   PubMed Web of Science ®Google Scholar
• Weir, R.A., et al., 2010. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. Journal of the american college of cardiology, 55 (3), 243–250.
   PubMed Web of Science ®Google Scholar
• Wittstein, I.S., et al., 2005. Neurohumoral features of myocardial stunning due to sudden emotional stress. New England journal of medicine, 352 (6), 539–548.
   PubMed Web of Science ®Google Scholar
• Wu, A.H., et al., 2012. Results of novel cardiac biomarkers in Tako-tsubo cardiomyopathy. International journal of cardiology, 159 (1), 53–55.
   PubMed Web of Science ®Google Scholar
• Zelinka, T., et al., 2007. Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation, 14 (1), 57–64.
   PubMed Web of Science ®Google Scholar